Current Cancer Drug Targets


Ruiwen Zhang
Center for Drug Discovery
University of Houston
3455 Cullen Blvd.
Houston, TX 77204


Targeting Oncogenes and Tumor Suppressors genes to Mitigate Chemoresistance

Volume:14   Issue:7
Pp: 599-609
Tahereh Fatemian and Ezharul Hoque Chowdhury
DOI: 10.2174/156800961407140926104458

The Role of CD40 Expression in Dendritic Cells in Cancer Biology; A Systematic Review

Volume:14   Issue:7
Pp: 610-620
Gui Han Lee, Alan Askari, George Malietzis, David Bernardo, Susan K. Clark, Stella C. Knight and Hafid Omar Al-Hassi
DOI: 10.2174/1568009614666140828103253

The Important Roles of miR-205 in Normal Physiology, Cancers and as a Potential Therapeutic Target

Volume:14   Issue:7
Pp: 621-637
Haleh Vosgha, Ali Salajegheh, Robert Anthony Smith and Alfred King-Yin Lam
DOI: 10.2174/156800961407140926105634

Analogs of Cinnamic Acid Benzyl Amide As Nonclassical Inhibitors of Activated JAK2 Kinase

Volume:14   Issue:7
Pp: 638-651
Marcin Mielecki, Małgorzata Milner-Krawczyk, Krystyna Grzelak, Damian Mielecki, Krystiana A. Krzysko, Bogdan Lesyng and Waldemar Priebe
DOI: 10.2174/1568009614666140821122718

Deregulated Expression of miR-224 and its Target Gene: CD59 Predicts Outcome of Diffuse Large B-cell Lymphoma Patients Treated with R-CHOP

Volume:14   Issue:7
Pp: 659-670
Guoqi Song, Guorong Song, Huiyun Ni, Ling Gu, Hong Liu, Baoan Chen, Bangshun He, Yuqin Pan, Shukui Wang and William C. Cho
DOI: 10.2174/1568009614666140818211103